Clinical trials recruiting for Pancreatic Neoplasms
38
Recruiting trials
12
US states with sites
19
Countries
18%
Accept healthy volunteers
Phase breakdown
Drugs and treatments being studied
Where trials are recruiting (top US states)
| State | Recruiting trials |
|---|---|
| California | 3 |
| Connecticut | 3 |
| Maryland | 3 |
| Wisconsin | 3 |
| Arizona | 1 |
| Florida | 1 |
| Illinois | 1 |
| Louisiana | 1 |
| New Jersey | 1 |
| Pennsylvania | 1 |
| South Carolina | 1 |
| Texas | 1 |
Top cities
Milwaukee, Wisconsin 3Norwalk, Connecticut 3Bethesda, Maryland 2Baltimore, Maryland 1Houston, Texas 1Jefferson, Louisiana 1Monrovia, California 1Morristown, New Jersey 1New Haven, Connecticut 1Newport Beach, California 1
Self-screener
Recruiting trials
- A Liquid Biopsy for Pancreatic Cancer Early-detection and Disease Monitoring
- A Pancreatic Cancer Screening Study in Hereditary High Risk Individuals
- A Pancreatic Cancer Screening Study in Individuals With New-Onset or Deteriorating Diabetes Mellitus
- A Phase I/II Trial of UCB4594 in Participants With Advanced Cancer
- Anti-Mesothelin TNaive/SCM hYP218 (TNhYP218) CAR T Cells in Participants With Mesothelin-Expressing Solid Tumors Including Mesothelioma
- Artidis Nanomechanical Signature Profiling of Pancreatic Cancer Specimens
- Cadonilimab Combined With S-1 or Capecitabine as Second-line Treatment for Advanced Pancreatic Cancer
- Clinical, Oncologic, and Metabolic Effects of Pancreatic Mass Loss After Pancreatectomy in Non-Diabetic Patients
- Construction of Molecular Diagnostic Marker Model for Pancreatic Cystic Tumors Based on Pancreatic Cystic Fluid Samples
- Determining Individualized Cancer Therapy in Pancreatic Cancer
- Diagnosis of Multiple Cancer and Monitoring of Minimal Residual Tumors After Treatment Using Blood and High-Sensitivity Genetic Analysis Techniques
- Diagnostic Strategies, Risk Assessment and Progression of Pancreatic Cysts
- Discovery of Soluble Biomarkers for Pancreatic Cancer Using Innovative All-Patient Inclusive Methodology
- EUS-guided RFA for Pancreatic Neoplasms
- Energy Expenditure and Nutrition After Pancreatic Surgery
- ExoLuminate Study for Early Detection of Pancreatic Cancer
- HTL0039732 in Participants With Advanced Solid Tumours
- Hepatic Arterial Infusion of Sodium Bicarbonate (NaHCO3) Combined With NASOX Regimen and Programmed Death-1 (PD-1) Inhibitors for Pancreatic Cancer Liver Metastases
- Indocyanine Green-Guided Versus Standard Laparoscopic Distal Pancreatectomy for Pancreatic Body and Tail Lesions
- Institut Paoli-Calmettes Pancreatic Neoplasms Database
- Intraoperative Hypotension in Pancreatoduodenectomy: A Randomized Trial of General Versus Combined Anesthesia
- Laparoscopic Versus Robot-assisted Left-sided Pancreatectomy for Benign and Pre-malignant Lesions (DIPLOMA-3)
- Mutant KRAS G12V-specific TCR Transduced T Cell Therapy for Advanced Pancreatic Cancer
- PET Imaging of Solid Tumors by a Novel Tracer, 68Ga-FAPI
- Pancreatic Cancer Detection Consortium
- Pancreatic Cancer Screening Through the Detection of Elastase-1 Combined With Other Examinations
- Pancreatic Cancer Screening Using the Enzeavour Assay in Japan
- Pancreatic Surgical Database
- Registry of Pancreatic Disease
- Single-cell Sequencing Analysis of Resectable/Borderline Resectable Pancreatic Cancer Patients
- Spanish Series of Patients Treated With the Radionuclide Lutetium177
- Study of KRAS Neoantigen mRNA Vaccine (ABO2102) in Patients With KRAS -Mutated Solid Tumors
- Surufatinib Plus Camrelizumab and AS in First Line Treatment of Advanced Metastatic Pancreatic Cancer
- Tamoxifen for Advanced Solid Pseudopapillary Tumor of the Pancreas
- The MOMENTUM Study: The Multiple Outcome Evaluation of Radiation Therapy Using the MR-Linac Study
- The Role of MicroRNA in the Diagnosis, Prognosis and Response to Treatment in Pancreatic Cancer
- Tissue Procurement and Natural History Study of Patients With Malignant Mesothelioma
- UCSF PANC Cyst Registry
Related conditions
Trials recruiting for Pancreatic Neoplasms often also study these conditions. Each links to its own recruiting-trial list.
Pancreatic cancer 870Stomach Neoplasms 11Pancreatic Ductal Adenocarcinoma 64Lung cancer 2180Pancreas Cancer 86Colorectal cancer 1359Pancreatic Diseases 9Ovarian Neoplasms 18Lung Neoplasms 33Esophageal Neoplasms 7
Common questions
Are these trials free to join?
Study-related care in a clinical trial is usually provided at no cost to participants, and some trials reimburse travel. Costs vary by study - the trial team will explain what is and is not covered. Confirm this directly with them.
How do I know if I am eligible for Pancreatic Neoplasms trials?
Each trial lists inclusion and exclusion criteria. The screener above checks stated age and sex only. The full eligibility (your medical history, current medications, test results) is assessed by the study team. Open any trial to read its criteria, then contact the site.
Is this list complete?
No. For the full list, search ClinicalTrials.gov.